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S U M M A R Y
Objective: The outcome of leptospirosis after the resolution of acute disease, either spontaneously or
after treatment, is not well described. The aim of this study was to assess the possible sequelae of acute
leptospirosis after hospital discharge.
Methods: We report here a prospective study carried out in Sa˜o Paulo, Brazil in which patients
hospitalized for leptospirosis were followed in the outpatient setting.
Results: Forty-seven patients were serially assessed: 32 severe and 15 mild cases. Early and late
complications were not common in either group, but subjective complaints were common in the ﬁrst
few weeks after hospital discharge (53% of severe cases, 40% of mild cases). Two patients had continuing
complaints: one had profound general malaise and the other developed new onset panic disorder. The
sample analyzed represented 26% of the patients hospitalized with leptospirosis in the city of Sa˜o Paulo
during the study period. The duration of follow-up was an average of approximately 20 days at the ﬁrst
visit, and approximately 40 days at the second visit. Forty-seven patients came for one follow-up visit
and 22 of the same patients had two follow-up visits.
Conclusions: While two of 47 patients reported continuing symptoms after hospitalization for acute
leptospirosis, no deﬁnitive, objective evidence of chronic sequelae due to this infection was proven.
While preliminary, these observations point to the need for a prospective, rigorous and systematic study
to deﬁnitively determine and characterize late complications and chronic disease after acute
leptospirosis.
 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Leptospirosis, a widespread bacterial zoonosis with a global
distribution, is caused by pathogenic spirochetes of the genus
Leptospira.1 The disease occurs in rural endemics and ﬂood-
associated urban outbreaks, and is associated with occupational
and recreational exposure.2 In large urban centers of tropical
developing countries, including Brazil, leptospirosis affects not
only occupational risk groups, but also the general population.
Transmission is closely related to environmental factors.3,4
The classic clinical presentation in leptospirosis is an acute
phase with bacteremia, with signs of an inﬂammatory response
lasting about a week, followed by an immune phase characterized
by antibody production and excretion of leptospires in the urine.1
Severe manifestations occur in 5–10% of human infections, typiﬁed
by the following: (1) Weil’s syndrome, a triad of jaundice,
hemorrhagic diathesis, and acute renal failure (with a 10–15%* Corresponding author. Tel.: +1 858 822 4469; fax: +1 858 822 5322.
E-mail address: jvinetz@ucsd.edu (J.M. Vinetz).
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doi:10.1016/j.ijid.2011.03.020case fatality in most series) and (2) severe pulmonary hemorrhage
syndrome (SPHS), which may present as acute respiratory distress
syndrome (ARDS) or massive pulmonary hemorrhage (with a case
fatality of >50% in many series). Severe manifestations also include
myocarditis and shock. Aseptic meningitis occurring during the
acute phase is thought to have a generally benign course and
therefore is considered a mild manifestation of leptospirosis.
After the initial infection, Leptospira disseminate to all organs;
the presence of spirochetes has been demonstrated in brain, heart,
lung, liver, spleen, and kidney by PCR and culture in humans and in
experimentally and naturally infected animals.1 Leptospirosis
manifests as acute disease, although leptospires can survive
immune defenses to cause chronic infection and colonization. The
deﬁnitive organ of persistence and colonization that leads to
transmission is the kidney, yet Leptospira persist not only in
proximal renal tubule, but also in eye and brain, resulting in
chronic disease that can manifest in humans as chronic meningitis,
uveitis, and also late complications including electrolyte dis-
orders.1 While the acute phase of disease is well described in
leptospirosis, few studies have focused on the patient follow-up
after hospitalization, early and late manifestations related toses. Published by Elsevier Ltd. All rights reserved.
A. Spichler et al. / International Journal of Infectious Diseases 15 (2011) e486–e490 e487leptospirosis after an acute episode, and possible chronic disease.5–8
The old observation that Leptospira are neurotropic and may persist
in brain,9 brings up the possibility of chronic sequelae. One
prospective evaluation of the recovery of renal function in
leptospirosis showed that urinary concentration capacity may not
recover even as long as 6 months after acute disease,10 a possible
clue to the potential for chronic complications.
Nonetheless, little is known about late complications of
leptospirosis in terms of clinically observable disease and the
rate of normalization of laboratory markers of disease, such as
renal function tests (serum creatinine), liver function tests
(transaminases, bilirubin, alkaline phosphatase), and hematologi-
cal parameters (primarily platelet counts), after acute leptospiro-
sis. The high incidence of leptospirosis in the city of Sa˜o Paulo,
Brazil, an endemic area where 80% of notiﬁed cases are
hospitalized,4,11 provides an opportunity to carry out follow-up
clinical observations of patients after hospitalization.
The aim of this study was to determine the frequency of early
and late medical complaints, possible chronic manifestations, and
laboratory abnormalities in severe and mild leptospirosis patients
at the ambulatory care level after hospital discharge.
2. Materials and methods
2.1. Data collection
A prospective follow-up study of patients hospitalized for acute
leptospirosis was performed from December 2008 to May 2009 at
the Emilio Ribas Institute of Infectious Diseases in Sa˜o Paulo, Brazil.
The diagnosis of leptospirosis was laboratory conﬁrmed in
clinically compatible cases by either ELISA immunoglobulin M
(IgM) (PanBio, Brisbane, Australia or Biomanguinhos, Sa˜o Paulo,
Brazil) kit, or microscopic agglutination test (MAT) with 20
leptospiral serovars (Table 1), with a single titer >1:800,
seroconversion, or a four-fold increase between two exams.
Patients hospitalized due to leptospirosis from any hospital in
the city of Sa˜o Paulo were contacted through the leptospirosis
surveillance system of the Health Municipality Department, and
were asked to attend the Emilio Ribas Hospital outpatient clinic no
more than 45 days immediately after discharge from the hospital
for a ﬁrst visit, and before 90 days for a second visit (whether or not
symptoms persisted). Patients were included in the study if they
had laboratory conﬁrmation of leptospirosis and wanted to
participate in the study. Patients identiﬁed with other acuteTable 1
Leptospiral serovars used in the microscopic agglutination test (MAT)
Serogroup Serovar Reference strain
Icterohaemorrhagiae Icterohaemorrhagiae RGA
Canicola Canicola Hond Utrecht IV
Pyrogenes Pyrogenes Salinem
Australis Australis Ballico
Shermani Shermani 1342 K
Andamana Andamana CH 11
Tarassovi Tarassovi Perepelitsin
Autumnalis Autumnalis Akiyami A
Djasiman Djasiman Djasiman
Javanica Javanica Veldrat Batavia 46
Ballum Castellonis Castello´n 3
Panama Panama CZ 214
Sejroe Wolfﬁ 3705
Pomona Pomona Pomona
Icterohaemorrhagiae Copenhageni M 20
Grippotyphosa Grippotyphosa Moskva V
Autumnalis Butembo Butembo
Bataviae Brasiliensis An 776
Cynopteri Cynopteri 3522 C
Sejroe Hardjo Hardjoprajitnoinfectious diseases during hospitalization were excluded from the
study.
Clinical, epidemiological, and laboratory data were collected
during the ﬁrst visit. A standardized data collection form was used
to collect the following information: age, gender, race, past medical
history, leptospirosis severity during hospitalization (oliguria,
jaundice, pulmonary involvement, shock, and meningitis), length
of hospitalization, and laboratory results at admission (when
available, including hemoglobin level, total bilirubin, platelet
count, serum creatinine, alanine aminotransferase (ALT), aspartate
aminotransferase (AST)) and during the routine visits (Figure 1).
For epidemiological data we inquired about the presumptive
mechanism of leptospirosis transmission reported by the patient,
and occupation. A comprehensive general medical history was
carried out and symptoms potentially related to leptospirosis
(fatigue, general malaise, myalgia, headache) were speciﬁcally
sought. In addition to the physical examination, all patients were
asked to undergo routine laboratory testing during the ﬁrst follow-
up visit. For persistent symptoms, patients continued to be seen at
the outpatient clinic until a diagnosis was clariﬁed.
2.2. Deﬁnitions
Acute renal failure was deﬁned according to the Acute Kidney
Injury Network criteria.12 Pulmonary involvement was deﬁned to
include dyspnea, hemoptysis, and intubation. The period of
hospitalization and the period between hospitalization and the
visits were analyzed in days. The major risk source of transmission
was identiﬁed on the basis of patient information and/or included
reports of direct or indirect contact with the urine of rats, ﬂooding,
recycling places, and sewers. Past medical conditions were reported
by the patients or were established from the medical charts.
Severe cases were deﬁned as those that presented with any
combination of jaundice, renal failure, hemorrhage, pulmonary
involvement, and shock during hospitalization. Mild cases were
deﬁned as those that presented with none of these clinical
manifestations.1,13
Panic disorder was deﬁned as recurring experience of
unexpected panic attacks, and at least one of the following: worry
about future attacks, phobic avoidance of situations that could
trigger an attack, and other change in behavior due to the attacks,
such as frequent medical or emergency room visits. Bronchitis was
described as an inﬂammation of the bronchi clinically presenting
as cough lasting more than 5 days after the acute phase of
leptospirosis. General malaise was as described by the patients.
This study was approved by the Infectious Diseases Research
Center of the Emilio Ribas Hospital, and written informed consent
was obtained from each patient enrolled in the study.
2.3. Statistical analysis
Statistical analysis was performed using SPSS (version 14.0;
SPSS, Chicago, IL, USA). Statistical differences between mild and
severe groups were determined with the Chi-square test or
Student’s t-test. The ﬁndings were considered statistically signiﬁ-
cant at a p-value of 0.05; results of the study were expressed as
mean with standard deviation and range for continuous variables,
and as percentages for discrete variables.
3. Results
From data available at the Health Municipality Secretariat
Surveillance Reference Center, approximately 180 leptospirosis
cases were hospitalized in the city of Sa˜o Paulo during the study
period, of whom 47 (26%) were enrolled in this study. Our goal was
to follow the majority of patients with acute leptospirosis after
Figure 1. Flow diagram of post-hospitalization follow-up of leptospirosis patients.
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could not be followed in this pilot study due to logistical difﬁculties
and ﬁnancial limitations or to the lack of any clinical symptoms
during that period. The patients enrolled in the study and those not
followed after discharge did not differ in age (mean age: 36  13
years) or gender (18% female and 82% male).
The majority of study subjects were men (85%), and the mean
age of study participants was 36  18 years. Subjects were mostly
from the mixed ethnic group (pardo; 66%), with smaller proportions
of white (24%) and black (10%) patients. The mean period of
hospitalization was 12  8 days. During hospitalization, patients
had the following clinical manifestations or complications: pulmo-
nary involvement (28%), jaundice (60%), renal failure (47%, nine
requiring dialysis), and shock (11%). Sixteen (34%) required support in
the intensive care unit. All patients were treated with either
crystalline penicillin or ceftriaxone during their admission, and for
a minimum period of 7 days. One patient presented with acute
meningitis. The following abnormal laboratory test results were
obtained in the acute phase of the disease: hemoglobin level:
11  2 g/dl, serum creatinine 3.6  2.7 mg/dl, total bilirubin
11  10 mg/dl, and platelet count 124.681  86.597  109/l. Serum
AST and ALT were 93  60 and 90  80 U/ml, respectively, during
hospitalization. Among the 47 patients enrolled in the study, 32 (68%)
had anti-Leptospira agglutinating antibodies, as determined by MAT,
with the highest titer against the Leptospira interrogans serogroupIcterohaemorrhagiae, the serovar known to be the predominant cause
of leptospirosis in this setting.14
The mean interval between ambulatory visits after hospital
discharge was 22  12 days. At the ﬁrst ambulatory visit, major
medical complaints were reported in 23/47 patients (49%): general
malaise (n = 10), persistent severe general malaise (n = 1), headache
(n = 3), myalgia (n = 2), dizziness (n = 1), bronchitis (n = 2), and
abdominal pain (n = 1); jaundice persisted in three cases at the ﬁrst
outpatient visit, varying from 15 to 50 days after onset of disease and
the ﬁrst visit.
The demographic, clinical, and laboratory features of patients
with severe and mild leptospirosis, during hospitalization and at
the ﬁrst visit, are shown in Table 2. During hospitalization,
hemoglobin and platelet counts were lower in those with severe
disease. Older age was more likely to be associated with severe
disease. The time between discharge and the ﬁrst visit was similar
for both groups (approximately 20 days), while laboratory results
showed slight abnormalities in the severe group.
Of severe cases, 17 (53%) had one or more medical complaints at
the ﬁrst visit. Of mild cases, six (40%) had any medical complaint at
the ﬁrst visit. Most mild cases were elementary to high school
students, ranging from 8 to 16 years of age; most severe cases were
manual laborers aged 25–57 years.
The most common risk factor for acquiring leptospirosis in both
groups appeared to be indirect or direct contact with rat urine. A
Table 2
Distribution of demographic, clinical, and laboratory features between severe and mild leptospirosis cases during hospitalization and at the ﬁrst visit
Variables Mild cases (n = 15) n (%) or mean  SD Severe cases (n = 32) n (%) or mean  SD p-Value
Demographic
Gender – male 12 (80%) 28 (88%) 0.2
Age, years 26.0  14 41  16 0.006
Acute phase
Days of hospitalization 6.5  3.4 15  9 0.0003
Jaundice 0 28 (88%) -
Renal failure 0 22 (69%) -
Pulmonary involvement 0 13 (41%) -
Shock 0 5 (16%) -
Requirement of ICU as inpatient 0 16 (50%) -
Platelet count ( 109/l) 179.150  89.499 101.838  75.628 0.004
Hemoglobin (g/dl) 12.1  1.6 10.7  2.2 0.02
Serum creatinine (mg/dl) 1.2  0.4 4.5  2.7 0.002
Serum total bilirubin (mg/dl) 1.5  1.0 14.0  10.5 0.001
Aspartate aminotransferase (IU/l) 79  43 95.0  91.0 0.2
Alanine aminotransferase (IU/l) 67  33 103.0  65.0 0.07
Follow-up features (ﬁrst visit)
Days between discharge and reexamination 24  14.0 21.0  11.0 0.5
Platelet count (109/l) 305.416  298.000 306.535  123.430 0.52
Hemoglobin (g/dl) 12.5  0.9 11.7  1.5 0.14
Serum creatinine (mg/dl) 1  0 1.1  0.3 0.2
Total serum bilirubin (mg/dl) 1  0 2.5  2.3 0.003
Aspartate aminotransferase (IU/l) 37  25 44  30 0.2
Alanine aminotransferase (IU/l) 26  14 34  14 0.2
ICU, intensive care unit; SD, standard deviation.
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primarily with ﬁve severe leptospirosis patients having hyperten-
sion. Table 3 shows a comparison of the past medical history of
mild and severe cases.
Of 47 patients, only 22 came for a second visit, presumably
because of distance from the hospital, a lack of symptoms, or a lack
of motivation. The mean time from discharge to the second visit
was 40  21 days. Of these patients, one continued to have profound
general malaise (not present prior to the acute leptospirosis episode
by report), and one had a new diagnosis of panic disorder. The other
patients had no complaints, but seemed to want a ﬁnal physical
examination and medical clearance. At this second visit, laboratory
exams were only carried out for patients with complaints.
The patient with profound general malaise underwent exten-
sive testing, including assessment of pulmonary, cardiac, and renal
involvement (all unrevealing). On detailed questioning, he denied
similar symptoms before acquiring leptospirosis and had worked
in manual labor and construction for many years. He had chronic
but controlled hypertension. All laboratory studies were normal.
On echocardiography, sinus bradycardia with diastolic dysfunction
was demonstrated. This patient still had profound general malaise
1 year later for no deﬁned reason, indicating a potential association
with antecedent leptospirosis.Table 3
Past medical history of patients before leptospirosis according to severity of disease
Past medical history Mild cases
(n = 15), n (%)
Severe cases
(n = 32), n (%)
Coronary artery disease - 1 (3)
Chronic hypertension - 5 (16)
Breast cancer - 1 (3)
Cocaine user - 2 (6)
Depression - 1 (3)
Hepatitis B - 1 (3)
Knee arthritis - 1 (3)
Kidney congenital 1 (7) 1 (3)
Mental disorder - 1 (3)
Pulmonary emphysema - 1 (3)
Stroke - 1 (3)
Wasting syndrome 1 (7) 1 (3)The patient with panic disorder was followed for 6 months by
the psychiatry unit and made a ﬁnal visit to our clinic with
symptoms controlled with medication. The patient had had severe
leptospirosis, but had not had any neurological symptoms and
signs during the acute phase. The diagnosis of meningitis was
excluded by lumbar puncture. He was healthy before acquiring
leptospirosis, with no history of any neurological or psychiatric
disorder.
No patient reported eye symptoms at either visit, indicating the
lack of uveitis in this patient population.
Urine samples were not collected from the patients, nor were
follow-up leptospirosis serologies performed.
4. Discussion
This pilot study was focused on the systematic, prospective
clinical observation of acute leptospirosis patients, with both
severe and mild disease, after hospital discharge. The goal was to
determine whether late complications or possible chronic
manifestations or sequelae were common. Of the 47 patients
observed (approximately 22% of the total cases reported in the
municipality during the study period), two appeared to have the
new onset of subjective medical complaints speciﬁcally related to
the episode of acute leptospirosis; one manifested as profound
malaise and the other as new onset of panic disorder. Both denied
similar symptoms prior to the acquired infection. Even in this small
study population, the presence of new onset and long-term
persistence of clinical symptoms after hospitalization for lepto-
spirosis is suggested but not deﬁnitively proven by objective
evidence.
Most patients who survive acute leptospirosis are thought to
recover completely, yet the biological properties of Leptospira
indicate the propensity of these spirochetes to cause chronic
infection, not just in kidney (proximal renal tubules), but also in
other organs including brain; 8,9,15–17 this is suggestive of the
possibility of chronic, perhaps subtle, sequelae. The most obvious
site of chronic infection is the kidney, which because of urine, is an
easily accessible organ for study. Acute kidney injury occurs in 40%
to 70% of identiﬁed acute leptospirosis episodes, usually recovering
without chronic complications.18 Other studies in which patients
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have demonstrated renal abnormalities as long as 90 days after
infection (serum creatinine or abnormal urinary/plasma osmolali-
ty10). In the present study we aimed to systematically follow
patients referred after acute leptospirosis; we were able to do so
for about one in ﬁve cases identiﬁed in the city of Sa˜o Paulo during
the study period. It is difﬁcult to follow patients after discharge
because of logistical and ﬁnancial limitations, particularly if they
lack important symptoms; this is a limitation of the present study.
The present study lays the groundwork for a larger, more
systematic, prospective and region-based study, which, if properly
ﬁnanced, would be able to have a larger patient population,
allowing us to deﬁnitely determine whether important sequelae of
leptospirosis occur, even in a minority of patients.
No patient reported changes in urine volume on follow-up.
Although urinary parameters were not measured after hospitali-
zation, most patients had normal serum creatinine levels at the
ﬁrst outpatient visit. The other sites of possible chronic infection
were examined. No patient complained of vision problems or had
signs or symptoms of uveitis. However, almost half of the patients
in our study had medical complaints that changed their normal
activities, primarily general malaise, myalgia, and persistent
headache, for up to about 20 days after discharge.
At the second visit, two patients had medical complaints that
prevented them from carrying out activities that they had
previously been able to do before being affected by leptospirosis.
In these patients, clinical symptoms persisted, but in the absence of
objective evidence of chronic infection, so that the mechanism of
these clinical sequelae could not be ascertained in this study. Other
infectious diseases, such as dengue fever or dengue hemorrhagic
fever/dengue shock syndrome have been associated with clinical
symptoms that continue after infection, but chronic viral infection
after dengue has not been demonstrated.19
A major limitation of this study is that we were not able to
evaluate all leptospirosis cases in the city of Sa˜o Paulo after
discharge, because the patients did not reliably return for follow-up,
making systematic analysis impossible. If we had been able to enroll
all or the majority of the patients in our pilot study, as was proposed,
the larger sample size would have provided more conﬁdence in the
proportion of patients with chronic sequelae after acute leptospiro-
sis. However, the number of patients related in our study with
possible chronic manifestations (two of 47 patients) after the acute
phase of leptospirosis shows a signiﬁcant burden of disease if disease
in a highly endemic area such as Brazil is considered.
Neurological manifestations are well documented in severe
leptospirosis and can present as meningitis, neuritis, cerebrovascu-
lar involvement, and psychosis.8,20 In the present study, one patient
developed a panic disorder after the acute leptospirosis episode,
without prior known psychiatric disorder; such an association with
leptospirosis has not previously been reported and this may not be
causally related. This patient was never diagnosed with meningitis
(lumbar puncture was not performed in the inpatient setting).
Although aseptic, acute meningitis is a well known clinical
manifestation of leptospirosis, chronic meningitis has also been
reported.21
Few reports have described signiﬁcant past medical conditions
associated with the severity of acute leptospirosis, although
chronic hypertension and alcoholism have been associated with
severity.22 In the present study, ﬁve patients with severe
leptospirosis had antecedent hypertension, but no mild cases
did. Larger studies are needed to determine the relevance of
preexisting hypertension to the outcome of leptospirosis.
Our results, based on clinical information and physical
examination, self-reported subjective complaints, and laboratory
exams obtained as clinically indicated (but not for all patients),
suggest the general concept that leptospirosis resolves in the vastmajority of cases without chronic complications or sequelae, such
as uveitis,23 chronic meningitis,21 or kidney involvement.10Most of
the complications are associated with localization of leptospires
within the tissues and thus occur during the second week of the
illness or later. Anecdotal reports suggest that leptospirosis may
induce chronic symptoms analogous to those produced by other
spirochete infections, such as Lyme disease, but the mechanisms
are still unknown and the causal association has not been proven.
However, no objective evidence supports or refutes this hypothe-
sis. Speciﬁc biomarkers of acute and chronic manifestations of
leptospirosis are not available other than speciﬁc serologies, PCR,
and culture. Larger, prospective, systematic and population-based
studies are now indicated to evaluate late complications or
possibly subtle, chronic sequelae, including the identiﬁcation of
biomarkers of such disease, after resolution of acute leptospirosis.
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